Oppenheimer Initiates Coverage on BMP Sunstone (BJGP) with an Outperform
BJGP Hot Sheet
Rating Summary:0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Oppenheimer initiates coverage on BMP Sunstone (Nasdaq: BJGP) with an Outperform. Price target $6.
To see more analyst ratings on BJGP Click Here.
BMP Sunstone Corporation, formerly Beijing Med-Pharm Corporation, is a specialty pharmaceutical company with over-the-counter (OTC) manufacturing, marketing and distribution based in China.
To see more analyst ratings on BJGP Click Here.
BMP Sunstone Corporation, formerly Beijing Med-Pharm Corporation, is a specialty pharmaceutical company with over-the-counter (OTC) manufacturing, marketing and distribution based in China.
You May Also Be Interested In
- UPDATE: William Blair Starts EPIQ Systems (EPIQ) at Outperform; Broad Suite of Solutions in Electronic Discovery Sector
- Wedbush Downgrades Maxwell Technologies (MXWL) to Neutral; Elevated Competitive and Supply Chain Risks
- Barrington Research Starts Continental Resources (CLR) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
